7 completed, 1 terminated. 7 Phase 1, 1 Phase 2.
By phase and status
Follow TAK-925: new trials by email Literature Review of TAK-925 trials Research Report on TAK-925
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery Danavorexton, Placebo - Sleep Apnea | Phase 2 | Terminated | 41 | 2023-05-11 | 2025-09-16 |
A Study of Danavorexton (TAK-925) in Adults With Obstructive Sleep Apnea Danavorexton, Placebo - Sleep Apnea | Phase 1 | Completed | 13 | 2022-03-10 | 2022-12-02 |
A Study of Danavorexton in Anesthetized Adults Danavorexton, Danavorexton Placebo, Propofol - Healthy Volunteers | Phase 1 | Completed | 28 | 2021-09-28 | 2022-05-10 |
A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic Hypersomnia TAK-925, TAK-925 Placebo - Idiopathic Hypersomnia | Phase 1 | Completed | 28 | 2020-01-26 | 2023-09-26 |
Study of TAK-925 in Participants With Obstructive Sleep Apnea (OSA) Who Are Experiencing Excessive Daytime Sleepiness (EDS) Despite Adequate Use of Continuous Positive Airway Pressure (CPAP) TAK-925, Placebo - Obstructive Sleep Apnea | Phase 1 | Completed | 25 | 2019-11-21 | 2020-04-20 |
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With Narcolepsy TAK-925, Placebo - Healthy Participants, Narcolepsy | Phase 1 | Completed | 57 | 2018-11-21 | 2020-12-08 |
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults TAK-925, TAK-925 Placebo, Modafinil - Healthy Volunteers | Phase 1 | Completed | 20 | 2018-05-09 | 2021-03-26 |
Phase 1 TAK-925 Study in Healthy Adult and Elderly Volunteers and Participants With Narcolepsy TAK-925, Placebo - Healthy Participants and Patients With Narcolepsy | Phase 1 | Completed | 58 | 2017-11-04 | 2021-03-30 |
Conditions studied
Sleep Apnea Syndromes (2) · Sleep Apnea, Obstructive (2) · Idiopathic Hypersomnia (1) · Narcolepsy (1)
Sponsors
Takeda (6) · Millennium Pharmaceuticals, Inc. (2)
Countries
United States (5) · Japan (3) · Australia (1)
Results publications
PMID 36883238, PMID 36934366, PMID 38296753